Serenack
Brand names,
Serenack
Analogs
Serenack
Brand Names Mixture
Serenack
Chemical_Formula
C16H13ClN2O
Serenack
RX_link
http://www.rxlist.com/cgi/generic/diazepam.htm
Serenack
fda sheet
Serenack
msds (material safety sheet)
Serenack
Synthesis Reference
Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)
Serenack
Molecular Weight
284.74 g/mol
Serenack
Melting Point
125-126oC
Serenack
H2O Solubility
Slightly soluble (50 mg/L)
Serenack
State
solid
Serenack
LogP
2.988
Serenack
Dosage Forms
Tablets; Injectable solution
Serenack
Indication
Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.
Serenack
Pharmacology
Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.
Serenack
Absorption
Essentially complete, with a bioavailability of 93%.
Serenack
side effects and Toxicity
Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.
Serenack
Patient Information
Serenack
Organisms Affected
Humans and other mammals